# EDGAR Filing Document

**Accession Number:** 0001975641
**File Stem:** 0001213900-26-033700
**Filing Date:** 2026-3
**Character Count:** 4388
**Document Hash:** ae4686554a4075e5f621bc0ee2b289bd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-033700.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0001213900-26-033700

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260324

**FILED AS OF DATE**: 20260325

**DATE AS OF CHANGE**: 20260324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zhengye Biotechnology Holding Ltd
- **CENTRAL INDEX KEY:** 0001975641
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** F4

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42450
- **FILM NUMBER:** 26787944

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** NO.1 LIANMENG STREET, JILIN ECONOMIC &
- **STREET 2:** TECHNICAL DEVELOPMENT ZONE
- **CITY:** JILIN
- **PROVINCE COUNTRY:** F4
- **BUSINESS PHONE:** 86-13844801919

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** NO.1 LIANMENG STREET, JILIN ECONOMIC &
- **STREET 2:** TECHNICAL DEVELOPMENT ZONE
- **CITY:** JILIN
- **PROVINCE COUNTRY:** F4

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16 UNDER**

**THE SECURITIES EXCHANGE ACT OF 1934**

For the month of March 2026

Commission File Number: 001-42450

**Zhengye Biotechnology Holding Limited**

**No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone**

**Jilin City, Jilin Province, China**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

 **Results of Zhengye Biotechnology Holding Limited's Annual General Meeting of Shareholders**

The Annual General Meeting of Shareholders (the "Meeting") of Zhengye Biotechnology Holding Limited (the "Company") was held at No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province, China, on March 24, 2026, at 8:00 a.m. ET, with the ability given to the shareholders to join virtually via live audio webcast at www.virtualshareholdermeeting.com/ZYBT2026.

At the close of business on February 12, 2026, the record date for the determination of shareholders entitled to vote at the Meeting, there were 47,391,376ordinary shares (the "Ordinary Shares") outstanding, each share being entitled to one (1) vote, constituting all of the outstanding voting securities of the Company. At the Meeting, the holders of 43,133,362 Ordinary Shares of the Company, representing 43,133,362 votes, were represented in person or by proxy, constituting a quorum.

At the Meeting, the shareholders of the Company adopted the following resolutions:

&nbsp;&nbsp;&nbsp;&nbsp;1. An ordinary resolution to approve the election of two director candidates;

&nbsp;&nbsp;&nbsp;&nbsp;2. An ordinary resolution to approve the re-election of certain current directors;

&nbsp;&nbsp;&nbsp;&nbsp;3. An ordinary resolution to approve the share reclassification;

&nbsp;&nbsp;&nbsp;&nbsp;4. An ordinary resolution to approve the share consolidation; and

&nbsp;&nbsp;&nbsp;&nbsp;5. A special resolution to approve the adoption of the new memorandum and articles of association of the
Company.

The results of the vote at the Meeting for the resolutions were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **\*** | **For** | **For** | **Against** | **Against** | **Abstain** | **Abstain** |
| No. 1 |  | 43092532 |  | 24730 |  | 16100 |
| No. 2 |  | 43090399 |  | 26743 |  | 16220 |
| No. 3 |  | 43023158 |  | 90024 |  | 20180 |
| No. 4 |  | 43088491 |  | 44771 |  | 100 |
| No. 5 |  | 43025957 |  | 91275 |  | 16130 |

---

\* The numbers in this column correspond to the resolutions enumerated in the third paragraph of this report.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 24, 2026

---

| | |
|:---|:---|
| **Zhengye Biotechnology Holding Limited** | **Zhengye Biotechnology Holding Limited** |
| By: | */s/ Songlin Song* |
| Name: | Songlin Song |
| Title: | Chief Executive Officer |

---